Download PDF
Previous article
Go back to website
Next article
If you have problems to see the content please click here
Other users also viewed these articles
Mepolizumab efficacy and safety in patients with eosinophilic granulomatosis with polyangiitis in real practice: Data from a Spanish retrospective multicentric register from Rheumatology departments
Francisco Rubiño Juárez; Rosario García de Vicuña; Esther Vicente; Esther Rodríguez Almaraz; Nuria Lozano Rivas; Mercedes Freire González; Alejandro Olivé Marqués; Annika Nack; Javier Narváez García; Patricia Moya Alvarado; Esther Uriarte Itzazelaia; Nerea Alcorta Lorenzo; José Luis Marenco de la Fuente; Consuelo Ramos; Valvanera Pinillos Aransay; Ricardo Blanco Alonso; Fabricio Benavides Villanueva; María Paz Martínez Vidal; Jesús María González Martín; Íñigo Rúa-Figueroa;
Reumatol Clin. 2025;21:
Eosinophilic granulomatosis with poliangiitis: Successful treatment with methotrexate and low-dose of mepolizumab
Luis Francisco Valdés-Corona; Patricia Aguilar-Dominguez; Ariel Jasqui-Bucay; Mariana Arroyo-Machiavelo;
Reumatol Clin. 2024;20:571-2
Multidisciplinary consensus on the use of hydroxychloroquine in patients with systemic lupus erythematosus
Íñigo Rúa-Figueroa; Tarek Carlos Salman-Monte; José María Pego Reigosa; María Galindo Izquierdo; Elvira Díez Álvarez; Antonio Fernández-Nebro; José Andrés Román Ivorra; Inmaculada Calvo Penades; Joseba Artaraz Beobide; Jaime Calvo Alén;
Reumatol Clin. 2024;20:312-9